Validation of the 2018 FIGO cervical cancer staging system

To validate the revised 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer, with a particular focus on stage IB and stage III disease. Two retrospective cohort studies were conducted using The Surveillance, Epidemiology, and End Results Program betwe...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2019-01, Vol.152 (1), p.87-93
Main Authors: Matsuo, Koji, Machida, Hiroko, Mandelbaum, Rachel S., Konishi, Ikuo, Mikami, Mikio
Format: Article
Language:English
Subjects:
2018
Cervical cancer
FIGO
International Federation of Gynecology and Obstetrics
Staging
Validation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To validate the revised 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer, with a particular focus on stage IB and stage III disease. Two retrospective cohort studies were conducted using The Surveillance, Epidemiology, and End Results Program between 1988 and 2014. The stage IB cohort consisted of node-negative FIGO stage IB1 (tumor size
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2018.10.026